YU58799A - Novi postupak za dobijanje farmakološki aktivne supstance - Google Patents

Novi postupak za dobijanje farmakološki aktivne supstance

Info

Publication number
YU58799A
YU58799A YU58799A YU58799A YU58799A YU 58799 A YU58799 A YU 58799A YU 58799 A YU58799 A YU 58799A YU 58799 A YU58799 A YU 58799A YU 58799 A YU58799 A YU 58799A
Authority
YU
Yugoslavia
Prior art keywords
preparation
active substance
pharmacologically active
new process
general formula
Prior art date
Application number
YU58799A
Other languages
English (en)
Inventor
Maria Bakonyi
Csatarine Nagy
Leventene Molnar
Antal Gajary
Edit Alattyani
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of YU58799A publication Critical patent/YU58799A/sh
Publication of RS49626B publication Critical patent/RS49626B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Postupak za dobijanje metil [2-(2-tienil)-etilamino]-(2-halogenofenil)-acetata opšte formule (VI) polazeći od acetamida opšte formule (VII) prema šemi: Postoje vredni farmaceutski aktivni sastojci antitrombičnog efekta medju jedinjenjima opšte formule (VI). [A process for the preparation of methyl-[2(2-thienyl)-ethylamino]-(2-halogenophenyl)-acetates of general formula (VI) starting from the acetamides of general formula (VII). There are valuable pharmaceutically active ingredients of antithrombotic effect among the compounds of general formula (VI).
YUP-587/99A 1997-05-13 1998-05-11 Novi postupak za dobijanje farmakološki aktivne supstance RS49626B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására

Publications (2)

Publication Number Publication Date
YU58799A true YU58799A (sh) 2002-06-19
RS49626B RS49626B (sr) 2007-08-03

Family

ID=90014236

Country Status (38)

Country Link
US (1) US6180793B1 (sh)
EP (1) EP0981529B1 (sh)
KR (1) KR100428238B1 (sh)
CN (1) CN1109036C (sh)
AR (1) AR014349A1 (sh)
AT (1) ATE212025T1 (sh)
AU (1) AU735702B2 (sh)
BR (1) BR9809112B1 (sh)
CA (1) CA2289623C (sh)
CO (1) CO4950564A1 (sh)
CZ (1) CZ292820B6 (sh)
DE (1) DE69803176T2 (sh)
DK (1) DK0981529T3 (sh)
DZ (1) DZ2487A1 (sh)
EE (1) EE03925B1 (sh)
EG (1) EG21973A (sh)
ES (1) ES2172141T3 (sh)
HK (1) HK1027350A1 (sh)
HR (1) HRP980240B1 (sh)
HU (1) HU222283B1 (sh)
ID (1) ID23018A (sh)
IL (1) IL132774A0 (sh)
IS (1) IS1883B (sh)
ME (1) ME01636B (sh)
MY (1) MY121299A (sh)
NO (1) NO325419B1 (sh)
NZ (1) NZ501577A (sh)
PL (1) PL194859B1 (sh)
PT (1) PT981529E (sh)
RS (1) RS49626B (sh)
RU (1) RU2172315C1 (sh)
SA (1) SA98190583B1 (sh)
SK (1) SK283700B6 (sh)
TR (1) TR199902783T2 (sh)
TW (1) TW552263B (sh)
UA (1) UA66359C2 (sh)
WO (1) WO1998051689A1 (sh)
ZA (1) ZA983921B (sh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (sh) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
US8907090B2 (en) 2003-11-03 2014-12-09 Cadila Healthcare Limited Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
EP1851231A2 (en) * 2005-02-24 2007-11-07 Teva Pharmaceutical Industries Ltd Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
RU2008146758A (ru) * 2006-04-27 2010-06-10 Инд-Свифт Лэборетриз Лимитед (In) Способ получения полиморфных форм клопидогрела гидросульфата
EP1931682A2 (en) * 2006-08-03 2008-06-18 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
EP2064217B1 (en) 2006-09-04 2011-01-19 Ranbaxy Laboratories Limited An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
WO2010046476A1 (en) * 2008-10-24 2010-04-29 Sandoz Ag A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
KR20010012511A (ko) 2001-02-15
EP0981529B1 (en) 2002-01-16
ES2172141T3 (es) 2002-09-16
JP4256478B2 (ja) 2009-04-22
EE03925B1 (et) 2002-12-16
NO995533D0 (no) 1999-11-12
JP2001525819A (ja) 2001-12-11
KR100428238B1 (ko) 2004-04-30
ZA983921B (en) 1998-11-09
SK283700B6 (sk) 2003-12-02
HUP9700885A2 (hu) 1999-09-28
IS1883B (is) 2003-08-15
DE69803176T2 (de) 2002-08-22
ME01636B (me) 2007-08-03
CZ292820B6 (cs) 2003-12-17
NO995533L (no) 1999-12-13
HUP9700885A3 (en) 2000-06-28
IL132774A0 (en) 2001-03-19
BR9809112A (pt) 2000-08-01
CN1255924A (zh) 2000-06-07
SK151699A3 (en) 2000-07-11
DK0981529T3 (da) 2002-04-22
TR199902783T2 (xx) 2000-04-21
SA98190583B1 (ar) 2006-08-19
HRP980240A2 (en) 1999-02-28
PT981529E (pt) 2002-06-28
CA2289623C (en) 2007-01-30
PL194859B1 (pl) 2007-07-31
ATE212025T1 (de) 2002-02-15
ID23018A (id) 1999-12-30
CZ393999A3 (cs) 2000-04-12
UA66359C2 (uk) 2004-05-17
PL336693A1 (en) 2000-07-03
EP0981529A1 (en) 2000-03-01
EE9900488A (et) 2000-06-15
TW552263B (en) 2003-09-11
DZ2487A1 (fr) 2004-07-30
BR9809112B1 (pt) 2010-10-05
EG21973A (en) 2002-05-31
AR014349A1 (es) 2001-02-28
IS5244A (is) 1999-11-11
HK1027350A1 (en) 2001-01-12
RU2172315C1 (ru) 2001-08-20
HRP980240B1 (en) 2003-02-28
RS49626B (sr) 2007-08-03
NZ501577A (en) 2001-10-26
HU222283B1 (hu) 2003-05-28
US6180793B1 (en) 2001-01-30
CN1109036C (zh) 2003-05-21
WO1998051689A1 (en) 1998-11-19
HUP9700885D0 (en) 1997-07-28
CO4950564A1 (es) 2000-09-01
CA2289623A1 (en) 1998-11-19
MY121299A (en) 2006-01-28
AU7444898A (en) 1998-12-08
DE69803176D1 (de) 2002-02-21
NO325419B1 (no) 2008-04-21
AU735702B2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
MY121299A (en) A new process for the preparation of a pharmacologically active substance
AU7444798A (en) New intermediates and process for the preparation thereof
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
MY113733A (en) Salts of an anti-migraine indole derivative
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
UA35609C2 (uk) Гетероцикліл-бензоїл-гуанідини, спосіб їх одержання (варіанти) і фармацевтична композиція, яка має здатність інгібувати целюлярний na+/h+-антиносій
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
EP2308496A3 (en) Formulation containing phosphate derivatives of electron transfer agents
CA2288637A1 (en) Process for the preparation of 2-[(2-thienyl)-ethylamino-(2-halogenophe nyl)-acetonitriles
MY116862A (en) New processes for preparing pesticidal intermediates
BG103751A (en) Process for preparing pesticidal intermediates
CA2234480A1 (en) Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
CA2016551A1 (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
NZ332545A (sh)
UA41981C2 (uk) Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
TR199902057T2 (xx) Benzotiazolon bile�iklerinin haz�rlanmas� i�in proses.
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
FR2659553B1 (fr) Procede de preparation de compositions homeopathiques a partir d'une solution initiale contenant une substance active.
CA2182148A1 (en) Process for the preparation of substituted aminocarbonyltriazolinones
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
NZ310438A (en) Imidazo[1,5a]pyridine derived serine protease inhibitors